DE60014885D1 - Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen - Google Patents
Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungenInfo
- Publication number
- DE60014885D1 DE60014885D1 DE2000614885 DE60014885T DE60014885D1 DE 60014885 D1 DE60014885 D1 DE 60014885D1 DE 2000614885 DE2000614885 DE 2000614885 DE 60014885 T DE60014885 T DE 60014885T DE 60014885 D1 DE60014885 D1 DE 60014885D1
- Authority
- DE
- Germany
- Prior art keywords
- cyclodextrines
- amphiphile
- imposing
- resolving
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905460 | 1999-04-29 | ||
FR9905460A FR2792942B1 (fr) | 1999-04-29 | 1999-04-29 | Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes |
PCT/FR2000/001102 WO2000066635A1 (fr) | 1999-04-29 | 2000-04-26 | Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60014885D1 true DE60014885D1 (de) | 2004-11-18 |
DE60014885T2 DE60014885T2 (de) | 2005-10-27 |
Family
ID=9545038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60014885T Expired - Lifetime DE60014885T2 (de) | 1999-04-29 | 2000-04-26 | Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen |
Country Status (7)
Country | Link |
---|---|
US (1) | US6858723B1 (de) |
EP (1) | EP1177217B1 (de) |
JP (1) | JP4698842B2 (de) |
AT (1) | ATE279446T1 (de) |
DE (1) | DE60014885T2 (de) |
FR (1) | FR2792942B1 (de) |
WO (1) | WO2000066635A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2495899A1 (en) * | 2002-08-15 | 2004-03-18 | Yunqing Liu | Solid nano pharmaceutical formulation and preparation method thereof |
PT1534340E (pt) | 2002-09-06 | 2012-03-13 | Cerulean Pharma Inc | Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente |
FR2850972B1 (fr) * | 2003-02-07 | 2005-03-11 | Commissariat Energie Atomique | Derives de per(3,6-anhydro) cyclodextrines, leur preparation et leur utilisation pour vehiculer des elements metalliques vers des cibles biologiques ou pour decontaminer des cibles ou fluides biologiques |
FR2861396B1 (fr) * | 2003-10-24 | 2005-12-16 | Commissariat Energie Atomique | Derives amphiphiles de cyclodextrines,leur procede de preparation et leurs utilisations |
EP1694713A1 (de) * | 2003-12-18 | 2006-08-30 | Ciba Specialty Chemicals Holding Inc. | Reaktive polysaccharidderivate und herstellung und verwendung davon |
US7851457B2 (en) * | 2004-01-29 | 2010-12-14 | Innovative Biologics, Inc. | β-Cyclodextrin derivatives |
US7737132B2 (en) * | 2005-01-28 | 2010-06-15 | Pinnacle Pharmaceuticals | β-cyclodextrin derivatives as antibacterial agents |
AU2007252967B2 (en) * | 2006-05-19 | 2011-11-10 | Viroblock S.A. | A composition for inactivating an enveloped virus |
FR2907455A1 (fr) * | 2006-10-18 | 2008-04-25 | Commissariat Energie Atomique | Oligosaccharides cycliques,notamment derives de cyclodextrines amphiphiles,substitues par un ou plusieurs groupements polycycles naturels,tels que les triterpenoides. |
JP2010516625A (ja) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス, インコーポレイテッド | 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート |
FR2919872B1 (fr) * | 2007-08-10 | 2009-12-18 | Commissariat Energie Atomique | Derives de cyclodextrines |
JP5364923B2 (ja) * | 2009-01-28 | 2013-12-11 | 学校法人福岡大学 | 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。 |
WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
US9051479B2 (en) * | 2012-10-12 | 2015-06-09 | Empire Technology Development Llc | Paints and coatings containing cyclodextrin additives |
CN105392804B (zh) * | 2013-08-09 | 2018-07-10 | 生物辐射实验室股份有限公司 | 采用修饰的环糊精的蛋白质检测 |
TW202009013A (zh) * | 2018-08-14 | 2020-03-01 | 優你康光學股份有限公司 | 具有功能性成分的隱形眼鏡及其產品 |
JPWO2021054063A1 (de) * | 2019-09-20 | 2021-03-25 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681868A1 (fr) * | 1991-09-30 | 1993-04-02 | Sederma Sa | Nouvelles substances amphiphiles derivees de cyclodextrines et leur utilisation dans des compositions cosmetiques. |
FR2736056B1 (fr) * | 1995-06-29 | 1997-08-08 | Commissariat Energie Atomique | Derives de cyclodextrines, leur preparation et leur utilisation pour incorporer des molecules hydrophobes dans des systemes de tensioactifs organises |
-
1999
- 1999-04-29 FR FR9905460A patent/FR2792942B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-26 JP JP2000615663A patent/JP4698842B2/ja not_active Expired - Fee Related
- 2000-04-26 AT AT00922751T patent/ATE279446T1/de not_active IP Right Cessation
- 2000-04-26 DE DE60014885T patent/DE60014885T2/de not_active Expired - Lifetime
- 2000-04-26 WO PCT/FR2000/001102 patent/WO2000066635A1/fr active IP Right Grant
- 2000-04-26 US US09/926,413 patent/US6858723B1/en not_active Expired - Fee Related
- 2000-04-26 EP EP00922751A patent/EP1177217B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002543249A (ja) | 2002-12-17 |
WO2000066635A1 (fr) | 2000-11-09 |
DE60014885T2 (de) | 2005-10-27 |
FR2792942B1 (fr) | 2001-06-08 |
EP1177217B1 (de) | 2004-10-13 |
EP1177217A1 (de) | 2002-02-06 |
JP4698842B2 (ja) | 2011-06-08 |
ATE279446T1 (de) | 2004-10-15 |
FR2792942A1 (fr) | 2000-11-03 |
US6858723B1 (en) | 2005-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60014885D1 (de) | Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen | |
BRPI0503828A (pt) | formulações contendo pó, aquosas, lìquidas, não alcoólicas | |
HUP0101649A2 (hu) | Poli(metilidén-malonát) tartalmú mikrogömbök, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE167185T1 (de) | Cyclische derivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
DE69333064D1 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
CY1112274T1 (el) | Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν | |
DK0941095T3 (da) | Forbedrede farmaceutiske sammensætninger | |
DE69626218D1 (de) | 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinon derivate, deren herstellung und deren verwendung als antibakterielle mittel | |
YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
CY1106890T1 (el) | Παραγωγα της ακριδινης και η χρηση τους ως φαρμακων | |
BR9915940A (pt) | Métodos e composições para restaurar a estabilidade conformacional de uma proteìna da famìlia p53 | |
ES2102478T3 (es) | Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen. | |
ES2091964T3 (es) | Tejido estabilizado frente a radiacion con caracteristicas de olor mejoradas. | |
HUP0400832A2 (hu) | Új amido-alkil-piperidin- és amido-alkil-piperazin-származékok, és ilyen származékokat hatóanyagként tartalmazó gyógyszerkészítmények | |
ATE401304T1 (de) | Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
KR960006915A (ko) | 췌장염의 치료 조성물 | |
HUP9902880A2 (hu) | Szteroid biszfoszfonátok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE316086T1 (de) | Clathrat von azithromycin-hydrat mit 1,2- propylenglykol, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung | |
Ol’khovich et al. | Inclusion complexes of hydroxypropyl-β-cyclodextrin with novel cytotoxic compounds: Solubility and thermodynamic properties | |
SE9202323L (sv) | N-metylerad bis-4-piperidylfosfit | |
BR0008510A (pt) | Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos | |
ES2186191T3 (es) | Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento. | |
SE7903687L (sv) | Cyklohexylkarboxylsyraderivat och sett att framstella desamma | |
ATE183190T1 (de) | Erythromycinderivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel | |
DE69824046D1 (de) | Tricyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |